Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Anti-death strategies against oxidative stress in grafted mesenchymal stem cells.

Chang W, Song BW, Moon JY, Cha MJ, Ham O, Lee SY, Choi E, Choi E, Hwang KC.

Histol Histopathol. 2013 Dec;28(12):1529-36. Epub 2013 Jun 13. Review.

PMID:
23760682
2.

Graphene oxide flakes as a cellular adhesive: prevention of reactive oxygen species mediated death of implanted cells for cardiac repair.

Park J, Kim B, Han J, Oh J, Park S, Ryu S, Jung S, Shin JY, Lee BS, Hong BH, Choi D, Kim BS.

ACS Nano. 2015 May 26;9(5):4987-99. doi: 10.1021/nn507149w. Epub 2015 May 1.

PMID:
25919434
3.

Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex.

Song H, Cha MJ, Song BW, Kim IK, Chang W, Lim S, Choi EJ, Ham O, Lee SY, Chung N, Jang Y, Hwang KC.

Stem Cells. 2010 Mar 31;28(3):555-63. doi: 10.1002/stem.302.

4.

Modification of mesenchymal stem cells for cardiac regeneration.

Song H, Song BW, Cha MJ, Choi IG, Hwang KC.

Expert Opin Biol Ther. 2010 Mar;10(3):309-19. doi: 10.1517/14712590903455997. Review.

PMID:
20132054
5.

Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia.

Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri MA, Ishibashi-Ueda H, Nagaya N, Yamagishi M.

Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1320-9. doi: 10.1152/ajpheart.01330.2008. Epub 2010 Feb 12. Erratum in: Am J Physiol Heart Circ Physiol. 2012 Aug 15;303(4):H496.

6.

Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand.

Rodrigues M, Turner O, Stolz D, Griffith LG, Wells A.

Cell Transplant. 2012;21(10):2171-87. doi: 10.3727/096368912X639035. Epub 2012 Apr 17.

7.

Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy.

Lee S, Choi E, Cha MJ, Hwang KC.

Oxid Med Cell Longev. 2015;2015:632902. doi: 10.1155/2015/632902. Epub 2015 Feb 2. Review.

8.

Aging increases the susceptivity of MSCs to reactive oxygen species and impairs their therapeutic potency for myocardial infarction.

Li L, Guo Y, Zhai H, Yin Y, Zhang J, Chen H, Wang L, Li N, Liu R, Xia Y.

PLoS One. 2014 Nov 13;9(11):e111850. doi: 10.1371/journal.pone.0111850. eCollection 2014.

9.

A 3D rotary renal and mesenchymal stem cell culture model unveils cell death mechanisms induced by matrix deficiency and low shear stress.

Shimony N, Avrahami I, Gorodetsky R, Elkin G, Tzukert K, Zangi L, Levdansky L, Krasny L, Haviv YS.

Nephrol Dial Transplant. 2008 Jun;23(6):2071-80. doi: 10.1093/ndt/gfn062. Epub 2008 Mar 14.

10.

Mesenchymal stem cells restore CCl4-induced liver injury by an antioxidative process.

Cho KA, Woo SY, Seoh JY, Han HS, Ryu KH.

Cell Biol Int. 2012;36(12):1267-74. doi: 10.1042/CBI20110634.

PMID:
23035905
11.

Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice.

Yan J, Tie G, Wang S, Messina KE, DiDato S, Guo S, Messina LM.

J Am Heart Assoc. 2012 Dec;1(6):e002238. doi: 10.1161/JAHA.112.002238. Epub 2012 Dec 19.

12.

[Mechanism for promoting repair of renal ischemia reperfusion injury by mesenchymal stem cells].

Tao YH, Ye L, Wang YM, Wang Z.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 Feb;15(2):157-61. Review. Chinese.

13.

Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury.

Liang H, Hou H, Yi W, Yang G, Gu C, Lau WB, Gao E, Ma X, Lu Z, Wei X, Pei J, Yi D.

Eur Heart J. 2013 Jun;34(22):1681-90. doi: 10.1093/eurheartj/ehr131. Epub 2011 May 23.

14.

Improve the viability of transplanted neural cells with appropriate sized neurospheres coated with mesenchymal stem cells.

Li X, Liu X, Tan Y, Tran V, Zhang N, Wen X.

Med Hypotheses. 2012 Aug;79(2):274-7. doi: 10.1016/j.mehy.2012.05.010. Epub 2012 May 31.

PMID:
22657917
15.

Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.

Yao Y, Zhang F, Wang L, Zhang G, Wang Z, Chen J, Gao X.

J Biomed Sci. 2009 Aug 20;16:74. doi: 10.1186/1423-0127-16-74.

16.

Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.

Zhang J, Chen GH, Wang YW, Zhao J, Duan HF, Liao LM, Zhang XZ, Chen YD, Chen H.

Chin Med J (Engl). 2012 Oct;125(19):3472-8.

17.

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

Williams AR, Hare JM.

Circ Res. 2011 Sep 30;109(8):923-40. doi: 10.1161/CIRCRESAHA.111.243147. Review.

18.

Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.

Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J.

Stem Cells Dev. 2012 Sep 20;21(14):2724-52. doi: 10.1089/scd.2011.0722. Epub 2012 May 9. Review.

PMID:
22468918
19.

Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.

Zhu H, Sun A, Zhu H, Li Z, Huang Z, Zhang S, Ma X, Zou Y, Hu K, Ge J.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):894-901. doi: 10.1161/ATVBAHA.114.303241. Epub 2014 Feb 20.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk